MOH

Molina Healthcare Inc

Add to Watchlist

Advanced Chart

156.600

+2.77(1.801%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

156.8059

Open

155.010

VWAP

155.19

Vol

168.86K

Mkt Cap

8.34B

Low

154.000

Amount

26.20M

EV/EBITDA(TTM)

1.67

Total Shares

58.58M

3.09B

EV/OCF(TTM)

5.76

P/S(TTM)

0.20

Molina Healthcare, Inc. is a provider of managed healthcare services under the Medicaid and Medicare programs, and through the state insurance marketplaces. The Company operates through four segments: Medicaid, Medicare, Marketplace and Other. The Medicaid, Medicare, and Marketplace segments represent the government-funded or sponsored programs under which it offers managed healthcare services. Medicaid provides healthcare and long-term services and support to low-income Americans. Medicare is a federal program that provides eligible persons aged 65 and over, and some disabled persons, with a variety of hospital, medical insurance, and prescription drug benefits. The Marketplace insurance exchanges allow individuals and small groups to purchase federally subsidized health insurance. It arranges healthcare services for its members through contracts with a network of providers, including independent physicians and physician groups, hospitals, ancillary providers, and pharmacies.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q3

FY2025Q4

FY2026Q1

11.02B

+6.56%

4.201

-30.1%

11.12B

+5.87%

3.468

-31.32%

11.92B

+6.96%

6.113

+0.54%

Estimates Revision

The market is revising Upward the revenue expectations for Molina Healthcare, Inc. (MOH) for FY2025, with the revenue forecasts being adjusted by 0.68% over the past three months. During the same period, the stock price has changed by -52.21%.

Revenue Estimates for FY2025

Revise Upward

+0.68%

In Past 3 Month

EPS Estimates for FY2025

Revise Downward

-14.58%

In Past 3 Month

Stock Price

Go Down

-52.21%

In Past 3 Month

15 Analyst Rating

41.03% Upside

Wall Street analysts forecast MOH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MOH is 220.85 USD with a low forecast of 166.00 USD and a high forecast of 330.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

4 Buy

10 Hold

1 Sell

Hold

41.03% Upside

Current: 156.600

Low

166.00

Averages

220.85

High

330.00

41.03% Upside

Current: 156.600

Low

166.00

Averages

220.85

High

330.00

Cantor Fitzgerald

Overweight -> Neutral

downgrade

$312 -> $210

2025-07-25

Reason

Cantor Fitzgerald

Price Target

$312 -> $210

2025-07-25

downgrade

Overweight -> Neutral

Reason

Cantor Fitzgerald last night downgraded Molina Healthcare to Neutral from Overweight with a price target of $210, down from $312. The firm cites a lack of clarity in the Medicaid and exchange markets for the downgrade. Many of the unknowns are industry-wide and outside of Molina's control, the analyst tells investors in a research note. Cantor says that since the company is heavily influenced by regulatory and policy changes, it has lowered conviction in Molina's turnaround timeline.

Baird

Neutral

downgrade

$373 -> $179

2025-07-25

Reason

Baird

Price Target

$373 -> $179

2025-07-25

downgrade

Neutral

Reason

Baird lowered the firm's price target on Molina Healthcare to $179 from $373 and keeps a Neutral rating on the shares as part of an update on the managed care and healthcare facilities group. The firm is increasingly cautious on Medicaid and the healthcare exchange.

Barclays

Equal Weight

downgrade

$270 -> $186

2025-07-25

Reason

Barclays

Price Target

$270 -> $186

2025-07-25

downgrade

Equal Weight

Reason

Barclays lowered the firm's price target on Molina Healthcare to $186 from $270 and keeps an Equal Weight rating on the shares following the Q2 report.

Truist

David MacDonald

Buy

Hold

downgrade

$335 -> $180

2025-07-25

Reason

Truist

David MacDonald

Price Target

$335 -> $180

2025-07-25

downgrade

Buy

Hold

Reason

Truist analyst David MacDonald downgraded Molina Healthcare to Hold from Buy with a price target of $180, down from $335. The company's Q2 results and reduced outlook were impacted by accelerating medical cost pressures across all business lines, the analyst tells investors in a research note. The firm cites the challenging medical cost trend environment for the downgrade.

BofA

Kevin Fischbeck

Underperform

downgrade

$190 -> $166

2025-07-25

Reason

BofA

Kevin Fischbeck

Price Target

$190 -> $166

2025-07-25

downgrade

Underperform

Reason

BofA analyst Kevin Fischbeck lowered the firm's price target on Molina Healthcare to $166 from $190 and keeps an Underperform rating on the shares. After commentary on the company's call that the base 2025 EPS to use for forecasting future years is closer to $15, the firm is lowering its 2026 and 2027 adjusted EPS estimates to $18.50 and $23.00, respectively.

UBS

Neutral

downgrade

$260 -> $180

2025-07-25

Reason

UBS

Price Target

$260 -> $180

2025-07-25

downgrade

Neutral

Reason

UBS lowered the firm's price target on Molina Healthcare to $180 from $260 and keeps a Neutral rating on the shares. Higher cost trends are leading to an uncertain outlook, the analyst tells investors in a research note.

See All Ratings

Valuation Metrics

The current forward P/E ratio for Molina Healthcare Inc (MOH.N) is 8.16, compared to its 5-year average forward P/E of 15.37. For a more detailed relative valuation and DCF analysis to assess Molina Healthcare Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Strongly Undervalued

5Y Average PE

15.37

Current PE

8.16

Overvalued PE

17.76

Undervalued PE

12.98

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Strongly Undervalued

5Y Average EV/EBITDA

9.01

Current EV/EBITDA

4.84

Overvalued EV/EBITDA

10.38

Undervalued EV/EBITDA

7.64

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Strongly Undervalued

5Y Average PS

0.51

Current PS

0.19

Overvalued PS

0.59

Undervalued PS

0.43

Financials

Annual

Quarterly

FY2025Q2

YoY :

+15.66%

11.43B

Total Revenue

FY2025Q2

YoY :

-14.22%

374.00M

Operating Profit

FY2025Q2

YoY :

-15.28%

255.00M

Net Income after Tax

FY2025Q2

YoY :

-8.12%

4.75

EPS - Diluted

FY2025Q2

YoY :

+39.84%

-344.00M

Free Cash Flow

FY2025Q2

YoY :

-9.16%

13.48

Gross Profit Margin - %

FY2025Q2

YoY :

-26.89%

2.23

Net Margin - %

FY2025Q2

YoY :

-6.36%

16.20

ROIC

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

107.6K

USD

3-6

Months

29.3M

USD

6-9

Months

0.0

USD

0-12

Months

39.8K

USD

Bought

0-3

1.6M

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

0-3

Months

0.0

Volume

3-6

Months

0.0

Volume

6-9

Months

570.5K

Volume

0-12

Months

0.0

Volume

Bought

0-3

0.0

Volume

Months

3-6

62.9K

Volume

Months

6-9

51.6K

Volume

Months

0-12

0.0

Volume

Months

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

16.0K

USD

6-9

Months

8.0K

USD

0-12

Months

0.0

USD

Bought

0-3

0.0

USD

Months

3-6

32.0K

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

107.6K

USD

3-6

Months

29.3M

USD

6-9

Months

0.0

USD

0-12

Months

39.8K

USD

Bought

0-3

1.6M

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

MOH News & Events

Events Timeline

2025-08-08 (ET)

2025-08-08

09:31:57

Judges reject 2 cases challenging Medicare negotiation, The Hill reports

2025-07-23 (ET)

2025-07-23

16:22:29

Molina Healthcare cuts FY25 EPS view to at least $19 from $21.50-$22.50

2025-07-23

16:21:26

Molina Healthcare reports Q2 adjusted EPS $5.48, consensus $5.53

News

7.0

08-11PRnewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Molina Healthcare, Inc. - MOH

7.0

08-09Globenewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Molina Healthcare, Inc. - MOH

5.0

08-07NASDAQ.COM

Thursday 8/7 Insider Buying Report: MUSA, MOH

People Also Watch

RPM International Inc

United Therapeutics Corp

Equitable Holdings Inc

Telkom Indonesia (Persero) Tbk PT

FAQ

What is Molina Healthcare Inc (MOH) stock price today?

The current price of MOH is 156.6 USD — it has increased 1.8 % in the last trading day.

MOH

Market Estimates

Valuation Metrics

Forward PE

Forward EV/EBITDA

Forward PS

Financials

Trading Trends

MOH News & Events

Events Timeline

News

People Also Watch

FAQ

What is Molina Healthcare Inc (MOH) stock price today?

What is Molina Healthcare Inc (MOH)'s business?

What is the price predicton of MOH Stock?

What is Molina Healthcare Inc (MOH)'s revenue for the last quarter?

What is Molina Healthcare Inc (MOH)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for Molina Healthcare Inc (MOH)'s fundamentals?

How many employees does Molina Healthcare Inc (MOH). have?

What is Molina Healthcare Inc (MOH) market cap?